Using flow cytometric analysis, we confirmed that tumor infiltrating Treg cells expressed higher level of Bcl6 than Treg cells derived from tumor dLNs and spleens (Figure 1B) in mice challenged with MC-38 cells subcutaneously (in situ model). The gene discussed is BCL6; the disease is neoplasm.